With EDTA Chelation Dr. Lamas found extraordinary results, particularly relating to diabetic patients

Dr. Gervasio Lamas is the Principal Investigator of the Trials to Access Chelation Therapy (TACT). After the initial 10-year TACT study, Dr. Lamas found extraordinary results, particularly relating to diabetic patients.

With such promising results, he was then asked to continue his studies through another trial, which is currently collecting data. This fascinating update shows an exciting look at the future of Chelation Therapy!